Epigenomics

Using epigenetic markers to guide chronic pain treatment and predict health outcomes

Updated

Abstract

Epigenetic mechanisms, including DNA methylation, may contribute to chronic pain disorders.

  • Chronic pain affects both patients and healthcare systems significantly.
  • DNA methylation and long non-coding RNAs are important regulators of gene expression linked to pain.
  • Alterations in DNA methylation and lncRNA expression may influence inflammation and nociceptive signaling pathways.
  • Changes in these epigenetic markers are associated with chronic primary pain conditions like fibromyalgia and chronic low back pain, as well as chronic secondary pain conditions such as rheumatoid arthritis.
  • DNA methylation-based epigenetic clocks may serve as potential biomarkers for disease risk and prognosis in chronic pain.
  • Lifestyle and environmental factors could shape epigenetic regulation, suggesting avenues for personalized pain management strategies.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free